The circadian clock and pathology of the ageing brain

Nature Reviews Neuroscience

Volumn 13, Issue 5, 2012, Pages 325-335

  Kondratova, Anna A ^a   Kondratov, Roman V ^b  

^a LERNER RESEARCH INSTITUTE   (United States)

^b CLEVELAND STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

REACTIVE OXYGEN METABOLITE;

AGING; ALZHEIMER DISEASE; AUTOPHAGY; BRAIN DISEASE; BRAIN FUNCTION; BRAIN METABOLISM; CELL PROLIFERATION; CIRCADIAN RHYTHM; COGNITIVE DEFECT; DEGENERATIVE DISEASE; GENE; HOMEOSTASIS; HORMONE RELEASE; HUMAN; HUNTINGTON CHOREA; MOOD DISORDER; NEUROPATHOLOGY; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; REVIEW; SLEEP DISORDER;

AGING; ANIMALS; BRAIN; CIRCADIAN CLOCKS; CIRCADIAN RHYTHM; COGNITION DISORDERS; HUMANS;

EID: 84859962240     PISSN: 1471003X     EISSN: 14710048     Source Type: Journal    
DOI: 10.1038/nrn3208     Document Type: Review

References (143)

1. Bell-Pedersen, D. et al. Circadian rhythms from multiple oscillators: lessons from diverse organisms. Nature Rev. Genet. 6, 544-556 (2005). (Pubitemid 40910431)
2. Bass, J. & Takahashi, J. S. Circadian integration of metabolism and energetics. Science 330, 1349-1354 (2011).
3. Gery, S. & Koeffler, H. P. Circadian rhythms and cancer. Cell Cycle 9, 1097-1103 (2010).
4. Young, M. E. The circadian clock within the heart: potential influence on myocardial gene expression, metabolism, and function. Am. J. Physiol. Heart Circ. Physiol. 290, H1-H16 (2006).
5. Kyriacou, C. P. & Hastings, M. H. Circadian clocks: genes, sleep, and cognition. Trends Cogn. Sci. 14, 259-267 (2010).
6. Dardente, H. & Cermakian, N. Molecular circadian rhythms in central and peripheral clocks in mammals. Chronobiol. Int. 24, 195-213 (2007). (Pubitemid 46643411)
7. Kondratov, R. V. A role of the circadian system and circadian proteins in aging. Ageing Res. Rev. 6, 12-27 (2007). (Pubitemid 46635286)
8. Hofman, M. A. & Swaab, D. F. Living by the clock: the circadian pacemaker in older people. Ageing Res. Rev. 5, 33-51 (2006). (Pubitemid 43139666)
9. Tranah, G. J. et al. Circadian activity rhythms and mortality: the study of osteoporotic fractures. J. Am. Geriatr. Soc. 58, 282-291 (2010).
10. Pace-Schott, E. F. & Spencer, R. M. Age-related changes in the cognitive function of sleep. Prog. Brain Res. 191, 75-89 (2011).
11. Gachon, F. & Bonnefont, X. Circadian clock-coordinated hepatic lipid metabolism: only transcriptional regulation? Aging (Albany NY) 2, 101-106 (2010).
12. Reppert, S. M. & Weaver, D. R. Coordination of circadian timing in mammals. Nature 418, 935-941 (2002). (Pubitemid 34976023)
13. Green, C. B., Takahashi, J. S. & Bass, J. The meter of metabolism. Cell 134, 728-742 (2008).
14. Ko, C. H. & Takahashi, J. S. Molecular components of the mammalian circadian clock. Hum. Mol. Genet. 15 (Suppl. 2), R271-R277 (2006). (Pubitemid 44446803)
15. Shearman, L. P. et al. Interacting molecular loops in the mammalian circadian clock. Science 288, 1013-1019 (2000). (Pubitemid 30324228)
16. Nakahata, Y., Grimaldi, B., Sahar, S., Hirayama, J. & Sassone-Corsi, P. Signaling to the circadian clock: plasticity by chromatin remodeling. Curr. Opin. Cell Biol. 19, 230-237 (2007). (Pubitemid 46386412)
17. Hirayama, J. & Sassone-Corsi, P. Structural and functional features of transcription factors controlling the circadian clock. Curr. Opin. Genet. Dev. 15, 548-556 (2005). (Pubitemid 41262412)
18. Harms, E., Kivimae, S., Young, M. W. & Saez, L. Posttranscriptional and posttranslational regulation of clock genes. J. Biol. Rhythms 19, 361-373 (2004). (Pubitemid 39238205)
19. Bunger, M. K. et al. Mop3 is an essential component of the master circadian pacemaker in mammals. Cell 103, 1009-1017 (2000). (Pubitemid 32037390)
20. Shi, S. et al. Circadian clock gene Bmal1 is not essential; functional replacement with its paralog, Bmal2. Curr. Biol. 20, 316-321 (2010).
21. Reddy, A. B. & O'Neill, J. S. Healthy clocks, healthy body, healthy mind. Trends Cell Biol. 20, 36-44 (2010).
22. Wulff, K., Gatti, S., Wettstein, J. G. & Foster, R. G. Sleep and circadian rhythm disruption in psychiatric and neurodegenerative disease. Nature Rev. Neurosci. 11, 589-599 (2010).
23. Gerstner, J. R. et al. Cycling behavior and memory formation. J. Neurosci. 29, 12824-12830 (2009).
24. McClung, C. A. Circadian genes, rhythms and the biology of mood disorders. Pharmacol. Ther. 114, 222-232 (2007). (Pubitemid 46561535)
25. McClung, C. A. Circadian rhythms and mood regulation: Insights from pre-clinical models. Eur. Neuropsychopharmacol. 21 (Suppl. 4) S683-S693 (2011).
26. Roybal, K. et al. Mania-like behavior induced by disruption of CLOCK. Proc. Natl Acad. Sci. USA 104, 6406-6411 (2007). (Pubitemid 47186107)
27. Bellet, M. M., Vawter, M. P., Bunney, B. G., Bunney, W. E. & Sassone-Corsi, P. Ketamine influences CLOCK:BMAL1 function leading to altered circadian gene expression. PLoS ONE 6, e23982 (2011).
28. Gerstner, J. R. & Yin, J. C. Circadian rhythms and memory formation. Nature Rev. Neurosci. 11, 577-588 (2010).
29. Kondratova, A. A., Dubrovsky, Y. V., Antoch, M. P. & Kondratov, R. V. Circadian clock proteins control adaptation to novel environment and memeory formation. Aging (Albany NY) 2, 285-297 (2010).
30. Lyons, L. C. & Roman, G. Circadian modulation of short-term memory in Drosophila. Learn. Mem. 16, 19-27 (2009).
31. Van der Zee, E. A. et al. Circadian time-place learning in mice depends on Cry genes. Curr. Biol. 18, 844-848 (2008).
32. Garcia, J. A. et al. Impaired cued and contextual memory in NPAS2-deficient mice. Science 288, 2226-2230 (2000). (Pubitemid 30429610)
33. Sakai, T., Tamura, T., Kitamoto, T. & Kidokoro, Y. A clock gene, period, plays a key role in long-term memory formation in Drosophila. Proc. Natl Acad. Sci. USA 101, 16058-16063 (2004). (Pubitemid 39507926)
34. Wang, L. M. et al. Expression of the circadian clock gene Period2 in the hippocampus: possible implications for synaptic plasticity and learned behaviour. ASN Neuro 1, e00012 (2009).
35. Wyatt, J. K., Ritz-De Cecco, A., Czeisler, C. A. & Dijk, D. J. Circadian temperature and melatonin rhythms, sleep, and neurobehavioral function in humans living on a 20-h day. Am. J. Physiol. 277, R1152-R1163 (1999). (Pubitemid 29525972)
36. Eckel-Mahan, K. L. et al. Circadian oscillation of hippocampal MAPK activity and cAMP: implications for memory persistence. Nature Neurosci. 11, 1074-1082 (2008).
37. Eckel-Mahan, K. L. & Storm, D. R. Circadian rhythms and memory: not so simple as cogs and gears. EMBO Rep. 10, 584-591 (2009).
38. Tu, B. P., Kudlicki, A., Rowicka, M. & McKnight, S. L. Logic of the yeast metabolic cycle: temporal compartmentalization of cellular processes. Science 310, 1152-1158 (2005). (Pubitemid 41681736)
39. Chen, Z., Odstrcil, E. A., Tu, B. P. & McKnight, S. L. Restriction of DNA replication to the reductive phase of the metabolic cycle protects genome integrity. Science 316, 1916-1919 (2007). (Pubitemid 47025794)
40. Reddy, A. B. et al. Circadian orchestration of the hepatic proteome. Curr. Biol. 16, 1107-1115 (2006). (Pubitemid 43815745)
41. Albrecht, U. Molecular orchestration of the hepatic circadian symphony. Genome Biol. 7, 234 (2006).
42. Akhtar, R. A. et al. Circadian cycling of the mouse liver transcriptome, as revealed by cDNA microarray, is driven by the suprachiasmatic nucleus. Curr. Biol. 12, 540-550 (2002). (Pubitemid 34271367)
43. Panda, S. et al. Coordinated transcription of key pathways in the mouse by circadian clock. Cell 109, 307-320 (2002). (Pubitemid 34606874)
44. Panda, S. & Hogenesch, J. B. It's all in the timing: many clocks, many outputs. J. Biol. Rhythms 19, 374-387 (2004). (Pubitemid 39238206)
45. Hastings, M. H., Maywood, E. S. & Reddy, A. B. Two decades of circadian time. J. Neuroendocrinol. 20, 812-819 (2008). (Pubitemid 351858734)
46. Nakada, D., Levi, B. P. & Morrison, S. J. Integrating physiological regulation with stem cell and tissue homeostasis. Neuron 70, 703-718 (2011).
47. Goergen, E. M., Bagay, L. A., Rehm, K., Benton, J. L. & Beltz, B. S. Circadian control of neurogenesis. J. Neurobiol. 53, 90-95 (2002).
48. Guzman-Marin, R., Suntsova, N., Bashir, T., Szymusiak, R. & McGinty, D. Cell proliferation in the dentate gyrus of the adult rat fluctuates with the light-dark cycle. Neurosci. Lett. 422, 198-201 (2007). (Pubitemid 47077602)
49. Joshi, D., Barnabas, R., Martin, E. R., Parihar, V. & Kanojiya, M. Aging alters properties of the circadian pacemaker controlling the locomotor activity rhythm in males of Drosophila nasuta. Chronobiol. Int. 16, 751-758 (1999).
50. Rezaval, C. et al. A functional misexpression screen uncovers a role for enabled in progressive neurodegeneration. PLoS ONE 3, e3332 (2008).
51. Zheng, X., Yang, Z., Yue, Z., Alvarez, J. D. & Sehgal, A. FOXO and insulin signaling regulate sensitivity of the circadian clock to oxidative stress. Proc. Natl Acad. Sci. USA 104, 15899-15904 (2007). (Pubitemid 350035396)
52. Koh, K., Evans, J. M., Hendricks, J. C. & Sehgal, A. A Drosophila model for age-associated changes in sleep:wake cycles. Proc. Natl Acad. Sci. USA 103, 13843-13847 (2006). (Pubitemid 44413995)
53. Froy, O. Circadian rhythms, aging, and life span in mammals. Physiology (Bethesda) 26, 225-235 (2011).
54. Zhdanova, I. V. et al. Aging of intrinsic circadian rhythms and sleep in a diurnal nonhuman primate, Macaca mulatta. J. Biol. Rhythms 26, 149-159 (2011).
55. Skene, D. J. & Swaab, D. F. Melatonin rhythmicity: effect of age and Alzheimer's disease. Exp. Gerontol. 38, 199-206 (2003). (Pubitemid 36110514)
56. Monk, T. H. Aging human circadian rhythms: conventional wisdom may not always be right. J. Biol. Rhythms 20, 366-374 (2005). (Pubitemid 41022979)
57. Monk, T. H., Buysse, D. J., Reynolds, C. F., Kupfer, D. J. & Houck, P. R. Circadian temperature rhythms of older people. Exp. Gerontol. 30, 455-474 (1995).
58. Zhang, Y. et al. Effects of aging on lens transmittance and retinal input to the suprachiasmatic nucleus in golden hamsters. Neurosci. Lett. 258, 167-170 (1998). (Pubitemid 29023574)
59. Lupi, D., Semo, M. & Foster, R. G. Impact of age and retinal degeneration on the light input to circadian brain structures. Neurobiol. Aging 33, 383-392 (2012).
60. Aujard, F. et al. Artificially accelerated aging by shortened photoperiod alters early gene expression (Fos) in the suprachiasmatic nucleus and sulfatoxymelatonin excretion in a small primate, Microcebus murinus. Neuroscience 105, 403-412 (2001). (Pubitemid 32728124)
61. Asai, M. et al. Circadian profile of Per gene mRNA expression in the suprachiasmatic nucleus, paraventricular nucleus, and pineal body of aged rats. J. Neurosci. Res. 66, 1133-1139 (2001). (Pubitemid 33135599)
62. Madeira, M. D., Sousa, N., Santer, R. M., Paula-Barbosa, M. M. & Gundersen, H. J. Age and sex do not affect the volume, cell numbers, or cell size of the suprachiasmatic nucleus of the rat: an unbiased stereological study. J. Comp. Neurol. 361, 585-601 (1995).
63. Roozendaal, B., van Gool, W. A., Swaab, D. F., Hoogendijk, J. E. & Mirmiran, M. Changes in vasopressin cells of the rat suprachiasmatic nucleus with aging. Brain Res. 409, 259-264 (1987). (Pubitemid 17077546)
64. Colwell, C. S. Linking neural activity and molecular oscillations in the SCN. Nature Rev. Neurosci. 12, 553-569 (2011).
65. Nygard, M., Hill, R. H., Wikstrom, M. A. & Kristensson, K. Age-related changes in electrophysiological properties of the mouse suprachiasmatic nucleus in vitro. Brain Res. Bull. 65, 149-154 (2005). (Pubitemid 40348800)
66. Beynon, A. L., Thome, J. & Coogan, A. N. Age and time of day influences on the expression of transforming growth factor-beta and phosphorylated SMAD3 in the mouse suprachiasmatic and paraventricular nuclei. Neuroimmunomodulation 16, 392-399 (2009).
67. Davidson, A. J., Yamazaki, S., Arble, D. M., Menaker, M. & Block, G. D. Resetting of central and peripheral circadian oscillators in aged rats. Neurobiol. Aging 29, 471-477 (2008). (Pubitemid 351215584)
68. Kawakami, F. et al. Loss of day-night differences in VIP mRNA levels in the suprachiasmatic nucleus of aged rats. Neurosci. Lett. 222, 99-102 (1997). (Pubitemid 27077319)
69. Kondratov, R. V., Kondratova, A. A., Gorbacheva, V. Y., Vykhovanets, O. V. & Antoch, M. P. Early aging and age-related pathologies in mice deficient in BMAL1, the core component of the circadian clock. Genes Dev. 20, 1868-1873 (2006). (Pubitemid 44088348)
70. Hendricks, J. C. et al. Gender dimorphism in the role of cycle (BMAL1) in rest, rest regulation, and longevity in Drosophila melanogaster. J. Biol. Rhythms 18, 12-25 (2003). (Pubitemid 37187304)
71. Dubrovsky, Y. V., Samsa, W. E. & Kondratov, R. V. Deficiency of circadian protein CLOCK reduces lifespan and increases age-related cataract development in mice. Aging (Albany NY) 2, 936-944 (2010).
72. Fu, L., Pelicano, H., Liu, J., Huang, P. & Lee, C. The circadian gene Period2 plays an important role in tumor suppression and DNA damage response in vivo. Cell 111, 41-50 (2002).
73. Antoch, M. P. et al. Disruption of the circadian clock due to the Clock mutation has discrete effects on aging and carcinogenesis. Cell Cycle 7, 1197-1204 (2008). (Pubitemid 351749273)
74. Yu, E. A. & Weaver, D. R. Disrupting the circadian clock: gene-specific effects on aging, cancer, and other phenotypes. Aging (Albany NY) 3, 479-493 (2010).
75. Colrain, I. M. Sleep and the brain. Neuropsychol. Rev. 21, 1-4 (2011).
76. Merrill, D. A. & Small, G. W. Prevention in psychiatry: effects of healthy lifestyle on cognition. Psychiatr. Clin. North Am. 34, 249-261 (2011).
77. Kaup, A. R., Mirzakhanian, H., Jeste, D. V. & Eyler, L. T. A review of the brain structure correlates of successful cognitive aging. J. Neuropsychiatry Clin. Neurosci. 23, 6-15 (2011).
78. Beekman, A. T. Neuropathological correlates of late-life depression. Expert Rev. Neurother. 11, 947-949 (2011).
79. Wolkowitz, O. M., Reus, V. I. & Mellon, S. H. Of sound mind and body: depression, disease, and accelerated aging. Dialogues Clin. Neurosci. 13, 25-39 (2011).
80. Magee, J. C. & Carmin, C. N. The relationship between sleep and anxiety in older adults. Curr. Psychiatry Rep. 12, 13-19 (2010).
81. George, O. et al. Low brain allopregnanolone levels mediate flattened circadian activity associated with memory impairments in aged rats. Biol. Psychiatry 68, 956-963 (2010).
82. Naismith, S. L., Lewis, S. J. & Rogers, N. L. Sleep-wake changes and cognition in neurodegenerative disease. Prog. Brain Res. 190, 21-52 (2011).
83. Stopa, E. G. et al. Pathologic evaluation of the human suprachiasmatic nucleus in severe dementia. J. Neuropathol. Exp. Neurol. 58, 29-39 (1999). (Pubitemid 29053023)
84. Zhou, J. N., Hofman, M. A. & Swaab, D. F. VIP neurons in the human SCN in relation to sex, age, and Alzheimer's disease. Neurobiol. Aging 16, 571-576 (1995).
85. Gabery, S. et al. Changes in key hypothalamic neuropeptide populations in Huntington disease revealed by neuropathological analyses. Acta Neuropathol. 120, 777-788 (2010).
86. Saper, C. B. & German, D. C. Hypothalamic pathology in Alzheimer's disease. Neurosci. Lett. 74, 364-370 (1987). (Pubitemid 17017971)
87. Pavese, N., Rivero-Bosch, M., Lewis, S. J., Whone, A. L. & Brooks, D. J. Progression of monoaminergic dysfunction in Parkinson's disease: a longitudinal 18F-dopa PET study. Neuroimage 56, 1463-1468 (2011).
88. Teipel, S. J. et al. The cholinergic system in mild cognitive impairment and Alzheimer's disease: an in vivo MRI and DTI study. Hum. Brain Mapp. 32, 1349-1362 (2011).
89. Yohrling, G. J. et al. Analysis of cellular, transgenic and human models of Huntington's disease reveals tyrosine hydroxylase alterations and substantia nigra neuropathology. Brain Res. Mol. Brain Res. 119, 28-36 (2003).
90. Brunnstrom, H., Friberg, N., Lindberg, E. & Englund, E. Differential degeneration of the locus coeruleus in dementia subtypes. Clin. Neuropathol. 30, 104-110 (2011).
91. Sterniczuk, R., Dyck, R. H., Laferla, F. M. & Antle, M. C. Characterization of the 3xTg-AD mouse model of Alzheimer's disease: part 1. Circadian changes. Brain Res. 1348, 139-148 (2011).
92. Kudo, T., Loh, D. H., Truong, D., Wu, Y. & Colwell, C. S. Circadian dysfunction in a mouse model of Parkinson's disease. Exp. Neurol. 232, 66-75 (2011).
93. Oakeshott, S. et al. Circadian abnormalities in motor activity in a BAC transgenic mouse model of Huntington's disease. PLoS Curr. 3, RRN1225 (2011).
94. Grimm, S., Hoehn, A., Davies, K. J. & Grune, T. Protein oxidative modifications in the ageing brain: consequence for the onset of neurodegenerative disease. Free Radic. Res. 45, 73-88 (2011).
95. Siqueira, I. R. et al. Total antioxidant capacity is impaired in different structures from aged rat brain. Int. J. Dev. Neurosci. 23, 663-671 (2005). (Pubitemid 41674505)
96. Kondratov, R. V., Vykhovanets, O., Kondratova, A. A. & Antoch, M. P. Antioxidant N-acetyl-l-cysteine ameliorates symptoms of premature aging associated with the deficiency of the circadian protein BMAL1. Aging (Albany NY) 1, 979-987 (2009).
97. Hardeland, R., Coto-Montes, A. & Poeggeler, B. Circadian rhythms, oxidative stress, and antioxidative defense mechanisms. Chronobiol. Int. 20, 921-962 (2003). (Pubitemid 37517510)
98. Belden, W. J. et al. The band mutation in Neurospora crassa is a dominant allele of ras-1 implicating RAS signaling in circadian output. Genes Dev. 21, 1494-1505 (2007). (Pubitemid 46955722)
99. Yoshida, Y., Iigusa, H., Wang, N. & Hasunuma, K. Cross-talk between the cellular redox state and the circadian system in Neurospora. PLoS ONE 6, e28227 (2011).
100. Krishnan, N., Davis, A. J. & Giebultowicz, J. M. Circadian regulation of response to oxidative stress in Drosophila melanogaster. Biochem. Biophys. Res. Commun. 374, 299-303 (2008).
101. O'Neill, J. S. & Reddy, A. B. Circadian clocks in human red blood cells. Nature 469, 498-503 (2011).
102. O'Neill, J. S. et al. Circadian rhythms persist without transcription in a eukaryote. Nature 469, 554-558 (2011).
103. Kang, T. H., Reardon, J. T., Kemp, M. & Sancar, A. Circadian oscillation of nucleotide excision repair in mammalian brain. Proc. Natl Acad. Sci. USA 106, 2864-2867 (2009).
104. Kang, T. H. & Sancar, A. Circadian regulation of DNA excision repair: implications for chrono-chemotherapy. Cell Cycle 8, 1665-1667 (2009).
105. Friguet, B., Bulteau, A. L., Chondrogianni, N., Conconi, M. & Petropoulos, I. Protein degradation by the proteasome and its implications in aging. Ann. NY Acad. Sci. 908, 143-154 (2000). (Pubitemid 30462000)
106. Cheung, Z. H. & Ip, N. Y. Autophagy deregulation in neurodegenerative diseases-recent advances and future perspectives. J. Neurochem. 118, 317-325 (2011).
107. Sachdeva, U. M. & Thompson, C. B. Diurnal rhythms of autophagy: implications for cell biology and human disease. Autophagy 4, 581-589 (2008).
108. Pfeifer, U. & Strauss, P. Autophagic vacuoles in heart muscle and liver. A comparative morphometric study including circadian variations in meal-fed rats. J. Mol. Cell Cardiol. 13, 37-49 (1981). (Pubitemid 11179473)
109. Pfeifer, U. & Scheller, H. A morphometric study of cellular autophagy including diurnal variations in kidney tubules of normal rats. J. Cell Biol. 64, 608-621 (1975).
110. Reme, C. E. & Sulser, M. Diurnal variation of autophagy in rod visual cells in the rat. Albrecht Von Graefes Arch. Klin. Exp. Ophthalmol. 203, 261-270 (1977). (Pubitemid 8184464)
111. Ma, D., Panda, S. & Lin, J. D. Temporal orchestration of circadian autophagy rhythm by C/EBPβ. EMBO J. 30, 4642-4651 (2011).
112. Cardinali, D. P., Furio, A. M. & Brusco, L. I. Clinical aspects of melatonin intervention in Alzheimer's disease progression. Curr. Neuropharmacol. 8, 218-227 (2010).
113. Srinivasan, V. et al. Role of melatonin in neurodegenerative diseases. Neurotox. Res. 7, 293-318 (2005).
114. Olakowska, E., Marcol, W., Kotulska, K. & Lewin-Kowalik, J. The role of melatonin in the neurodegenerative diseases. Bratisl. Lek. Listy 106, 171-174 (2005).
115. Srinivasan, V. et al. Melatonin in mood disorders. World J. Biol. Psychiatry 7, 138-151 (2006). (Pubitemid 44137014)
116. Mishima, K. et al. Melatonin secretion rhythm disorders in patients with senile dementia of Alzheimer's type with disturbed sleep-waking. Biol. Psychiatry 45, 417-421 (1999). (Pubitemid 29130438)
117. Aziz, N. A. et al. Delayed onset of the diurnal melatonin rise in patients with Huntington's disease. J. Neurol. 256, 1961-1965 (2009).
118. Gibbs, J. E. et al. The nuclear receptor REV-ERBα mediates circadian regulation of innate immunity through selective regulation of inflammatory cytokines. Proc. Natl Acad. Sci. USA 109, 582-587 (2012).
119. Castanon-Cervantes, O. et al. Dysregulation of inflammatory responses by chronic circadian disruption. J. Immunol. 185, 5796-5805 (2010).
120. Most, E. I., Scheltens, P. & Van Someren, E. J. Prevention of depression and sleep disturbances in elderly with memory-problems by activation of the biological clock with light-a randomized clinical trial. Trials 11, 19 (2010).
121. Singer, C. et al. A multicenter, placebo-controlled trial of melatonin for sleep disturbance in Alzheimer's disease. Sleep 26, 893-901 (2003). (Pubitemid 39610638)
122. Gehrman, P. R. et al. Melatonin fails to improve sleep or agitation in double-blind randomized placebo-controlled trial of institutionalized patients with Alzheimer disease. Am. J. Geriatr. Psychiatry 17, 166-169 (2009).
123. Serfaty, M., Kennell-Webb, S., Warner, J., Blizard, R. & Raven, P. Double blind randomised placebo controlled trial of low dose melatonin for sleep disorders in dementia. Int. J. Geriatr. Psychiatry 17, 1120-1127 (2002). (Pubitemid 35469219)
124. Mishima, K., Okawa, M., Hozumi, S. & Hishikawa, Y. Supplementary administration of artificial bright light and melatonin as potent treatment for disorganized circadian rest-activity and dysfunctional autonomic and neuroendocrine systems in institutionalized demented elderly persons. Chronobiol. Int. 17, 419-432 (2000). (Pubitemid 30366513)
125. Dowling, G. A. et al. Melatonin and bright-light treatment for rest-activity disruption in institutionalized patients with Alzheimer's disease. J. Am. Geriatr. Soc. 56, 239-246 (2008). (Pubitemid 351160692)
126. Feng, Z. et al. Melatonin alleviates behavioral deficits associated with apoptosis and cholinergic system dysfunction in the APP 695 transgenic mouse model of Alzheimer's disease. J. Pineal Res. 37, 129-136 (2004). (Pubitemid 39120217)
127. Matsubara, E. et al. Melatonin increases survival and inhibits oxidative and amyloid pathology in a transgenic model of Alzheimer's disease. J. Neurochem. 85, 1101-1108 (2003). (Pubitemid 36613258)
128. Pappolla, M. et al. Inhibition of Alzheimer β-fibrillogenesis by melatonin. J. Biol. Chem. 273, 7185-7188 (1998).
129. Singhal, N. K., Srivastava, G., Patel, D. K., Jain, S. K. & Singh, M. P. Melatonin or silymarin reduces maneb-and paraquat-induced Parkinson's disease phenotype in the mouse. J. Pineal Res. 50, 97-109 (2011).
130. Medeiros, C. A. et al. Effect of exogenous melatonin on sleep and motor dysfunction in Parkinson's disease. A randomized, double blind, placebo-controlled study. J. Neurol. 254, 459-464 (2007). (Pubitemid 46786720)
131. Dowling, G. A. et al. Melatonin for sleep disturbances in Parkinson's disease. Sleep Med. 6, 459-466 (2005). (Pubitemid 41245369)
132. Willis, G. L. The role of ML-23 and other melatonin analogues in the treatment and management of Parkinson's disease. Drug News Perspect. 18, 437-444 (2005). (Pubitemid 41789103)
133. Willis, G. L. Parkinson's disease as a neuroendocrine disorder of circadian function: dopamine-melatonin imbalance and the visual system in the genesis and progression of the degenerative process. Rev. Neurosci. 19, 245-316 (2008).
134. Pallier, P. N. et al. Pharmacological imposition of sleep slows cognitive decline and reverses dysregulation of circadian gene expression in a transgenic mouse model of Huntington's disease. J. Neurosci. 27, 7869-7878 (2007). (Pubitemid 47093825)
135. Pallier, P. N. & Morton, A. J. Management of sleep/wake cycles improves cognitive function in a transgenic mouse model of Huntington's disease. Brain Res. 1279, 90-98 (2009).
136. Maywood, E. S. et al. Disruption of peripheral circadian timekeeping in a mouse model of Huntington's disease and its restoration by temporally scheduled feeding. J. Neurosci. 30, 10199-10204 (2010).
137. Bertram, L. & Tanzi, R. E. Thirty years of Alzheimer's disease genetics: the implications of systematic meta-analyses. Nature Rev. Neurosci. 9, 768-778 (2008).
138. Hofman, M. A. & Swaab, D. F. Alterations in circadian rhythmicity of the vasopressin-producing neurons of the human suprachiasmatic nucleus (SCN) with aging. Brain Res. 651, 134-142 (1994). (Pubitemid 24222859)
139. Thomas, B. & Beal, M. F. Parkinson's disease. Hum. Mol. Genet. 16, R183-R194 (2007).
140. Wakabayashi, K., Tanji, K., Mori, F. & Takahashi, H. The Lewy body in Parkinson's disease: molecules implicated in the formation and degradation of α-synuclein aggregates. Neuropathology 27, 494-506 (2007). (Pubitemid 47459715)
141. Willis, G. L., Kelly, A. M. & Kennedy, G. A. Compromised circadian function in Parkinson's disease: enucleation augments disease severity in the unilateral model. Behav. Brain Res. 193, 37-47 (2008).
142. Browne, S. E. & Beal, M. F. Oxidative damage in Huntington's disease pathogenesis. Antioxid. Redox Signal. 8, 2061-2073 (2006). (Pubitemid 46489631)
143. Morton, A. J. et al. Disintegration of the sleep-wake cycle and circadian timing in Huntington's disease. J. Neurosci. 25, 157-163 (2005). (Pubitemid 40110776)